Figure 2.

Overview of Mendelian randomization studies involving polycystic ovary syndrome. Mendelian randomization studies of polycystic ovary syndrome as the outcome or as the exposure are summarized, with significant results at the top of the figure. Results of borderline significance are denoted with a question mark. Abbreviations: AMH, anti-Mullerian hormone; BMI, body mass index; CHD, coronary heart disease; DHEAS, dehydroepiandrosterone sulfate; ER, estrogen receptor; FEV₁, forced expiratory volume in 1 second; FVC forced vital capacity; HDL, high-density lipoprotein; LDL, low-density lipoprotein; SHBG, sex hormone-binding globulin; T2D, type 2 diabetes.